Publications by authors named "Mark Yap"

Claim this Profile
A
A Novel X-Linked Inhibitor of Apoptosis Deficient Variant Showing Attenuated Epstein-Barr Virus Response.
Youjia Zhong, Chiung-Hui Huang, Win Mar Soe, Koon Wing Chan, Mas Suhaila Isa, Mark Yap

J Pediatric Infect Dis Soc· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic impact of disease progression following front-line therapy in classical Hodgkin lymphoma.
Christopher A Yasenchak, Wan-Yu Tseng, Mark Yap, Debra Rembert, Debra A Patt

Leuk Lymphoma· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effectiveness of Tyrosine Kinase Inhibitors and Molecular Monitoring Patterns in Newly Diagnosed Patients With Chronic Myeloid Leukemia in the Community Setting.
Nicholas J Di Bella, Debajyoti Bhowmik, Menaka Bhor, Mark Yap, Brooke Middlebrook

Clin Lymphoma Myeloma Leuk· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequencing of Cabazitaxel and Abiraterone Acetate After Docetaxel in Metastatic Castration-Resistant Prostate Cancer: Treatment Patterns and Clinical Outcomes in Multicenter Community-Based US Oncology Practices.
Guru Sonpavde, Menaka Bhor, Daniel Hennessy, Debajyoti Bhowmik, Liji Shen, Mark Yap

Clin Genitourin Cancer· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-Line and Sequential Use of Pazopanib Followed by Mammalian Target of Rapamycin Inhibitor Therapy Among Patients With Advanced Renal Cell Carcinoma in a US Community Oncology Setting.
Nicholas J Vogelzang, Michelle D Hackshaw, Thomas E Hutson, Debajyoti Bhowmik, Mark Yap

Clin Genitourin Cancer· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis